ResDTA: Predicting Drug-Target Binding Affinity Using Residual Skip Connections
The discovery of novel drug target (DT) interactions is an important step in the drug development process. The majority of computer techniques for predicting DT interactions have focused on binary classification, with the goal of determining whether or not a DT pair interacts. Protein ligand interac...
Gespeichert in:
Veröffentlicht in: | arXiv.org 2023-03 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | arXiv.org |
container_volume | |
creator | Ghosh, Partho Haque, Md Aynal |
description | The discovery of novel drug target (DT) interactions is an important step in the drug development process. The majority of computer techniques for predicting DT interactions have focused on binary classification, with the goal of determining whether or not a DT pair interacts. Protein ligand interactions, on the other hand, assume a continuous range of binding strength values, also known as binding affinity, and forecasting this value remains a difficulty. As the amount of affinity data in DT knowledge-bases grows, advanced learning techniques such as deep learning architectures can be used to predict binding affinities. In this paper, we present a deep-learning-based methodology for predicting DT binding affinities using just sequencing information from both targets and drugs. The results show that the proposed deep learning-based model that uses the 1D representations of targets and drugs is an effective approach for drug target binding affinity prediction and it does not require additional chemical domain knowledge to work with. The model in which high-level representations of a drug and a target are constructed via CNNs that uses residual skip connections and also with an additional stream to create a high-level combined representation of the drug-target pair achieved the best Concordance Index (CI) performance in one of the largest benchmark datasets, outperforming the recent state-of-the-art method AttentionDTA and many other machine-learning and deep-learning based baseline methods for DT binding affinity prediction that uses the 1D representations of targets and drugs. |
format | Article |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_2789557358</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2789557358</sourcerecordid><originalsourceid>FETCH-proquest_journals_27895573583</originalsourceid><addsrcrecordid>eNqNi80KgkAUhYcgSMp3GGgt2EyT1s60aFeYrUVylGtyx-Zn0dun0AO0OpzznW9GPMb5Joi3jC2Ib0wXhiHbRUwI7pFrLk1WJAd607KGpwVsaaZdGxSVbqWlR8B62pKmAQT7oQ8z1dGC2lU9vb9goKlClKOr0KzIvKl6I_1fLsn6fCrSSzBo9XbS2LJTTuOIShbFeyEiLmL-3-sLp2g-BA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2789557358</pqid></control><display><type>article</type><title>ResDTA: Predicting Drug-Target Binding Affinity Using Residual Skip Connections</title><source>Free E- Journals</source><creator>Ghosh, Partho ; Haque, Md Aynal</creator><creatorcontrib>Ghosh, Partho ; Haque, Md Aynal</creatorcontrib><description>The discovery of novel drug target (DT) interactions is an important step in the drug development process. The majority of computer techniques for predicting DT interactions have focused on binary classification, with the goal of determining whether or not a DT pair interacts. Protein ligand interactions, on the other hand, assume a continuous range of binding strength values, also known as binding affinity, and forecasting this value remains a difficulty. As the amount of affinity data in DT knowledge-bases grows, advanced learning techniques such as deep learning architectures can be used to predict binding affinities. In this paper, we present a deep-learning-based methodology for predicting DT binding affinities using just sequencing information from both targets and drugs. The results show that the proposed deep learning-based model that uses the 1D representations of targets and drugs is an effective approach for drug target binding affinity prediction and it does not require additional chemical domain knowledge to work with. The model in which high-level representations of a drug and a target are constructed via CNNs that uses residual skip connections and also with an additional stream to create a high-level combined representation of the drug-target pair achieved the best Concordance Index (CI) performance in one of the largest benchmark datasets, outperforming the recent state-of-the-art method AttentionDTA and many other machine-learning and deep-learning based baseline methods for DT binding affinity prediction that uses the 1D representations of targets and drugs.</description><identifier>EISSN: 2331-8422</identifier><language>eng</language><publisher>Ithaca: Cornell University Library, arXiv.org</publisher><subject>Affinity ; Binding ; Computer techniques ; Deep learning ; Drugs ; Knowledge bases (artificial intelligence) ; Machine learning ; Representations</subject><ispartof>arXiv.org, 2023-03</ispartof><rights>2023. This work is published under http://arxiv.org/licenses/nonexclusive-distrib/1.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>780,784</link.rule.ids></links><search><creatorcontrib>Ghosh, Partho</creatorcontrib><creatorcontrib>Haque, Md Aynal</creatorcontrib><title>ResDTA: Predicting Drug-Target Binding Affinity Using Residual Skip Connections</title><title>arXiv.org</title><description>The discovery of novel drug target (DT) interactions is an important step in the drug development process. The majority of computer techniques for predicting DT interactions have focused on binary classification, with the goal of determining whether or not a DT pair interacts. Protein ligand interactions, on the other hand, assume a continuous range of binding strength values, also known as binding affinity, and forecasting this value remains a difficulty. As the amount of affinity data in DT knowledge-bases grows, advanced learning techniques such as deep learning architectures can be used to predict binding affinities. In this paper, we present a deep-learning-based methodology for predicting DT binding affinities using just sequencing information from both targets and drugs. The results show that the proposed deep learning-based model that uses the 1D representations of targets and drugs is an effective approach for drug target binding affinity prediction and it does not require additional chemical domain knowledge to work with. The model in which high-level representations of a drug and a target are constructed via CNNs that uses residual skip connections and also with an additional stream to create a high-level combined representation of the drug-target pair achieved the best Concordance Index (CI) performance in one of the largest benchmark datasets, outperforming the recent state-of-the-art method AttentionDTA and many other machine-learning and deep-learning based baseline methods for DT binding affinity prediction that uses the 1D representations of targets and drugs.</description><subject>Affinity</subject><subject>Binding</subject><subject>Computer techniques</subject><subject>Deep learning</subject><subject>Drugs</subject><subject>Knowledge bases (artificial intelligence)</subject><subject>Machine learning</subject><subject>Representations</subject><issn>2331-8422</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNqNi80KgkAUhYcgSMp3GGgt2EyT1s60aFeYrUVylGtyx-Zn0dun0AO0OpzznW9GPMb5Joi3jC2Ib0wXhiHbRUwI7pFrLk1WJAd607KGpwVsaaZdGxSVbqWlR8B62pKmAQT7oQ8z1dGC2lU9vb9goKlClKOr0KzIvKl6I_1fLsn6fCrSSzBo9XbS2LJTTuOIShbFeyEiLmL-3-sLp2g-BA</recordid><startdate>20230320</startdate><enddate>20230320</enddate><creator>Ghosh, Partho</creator><creator>Haque, Md Aynal</creator><general>Cornell University Library, arXiv.org</general><scope>8FE</scope><scope>8FG</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>HCIFZ</scope><scope>L6V</scope><scope>M7S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope></search><sort><creationdate>20230320</creationdate><title>ResDTA: Predicting Drug-Target Binding Affinity Using Residual Skip Connections</title><author>Ghosh, Partho ; Haque, Md Aynal</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_27895573583</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Affinity</topic><topic>Binding</topic><topic>Computer techniques</topic><topic>Deep learning</topic><topic>Drugs</topic><topic>Knowledge bases (artificial intelligence)</topic><topic>Machine learning</topic><topic>Representations</topic><toplevel>online_resources</toplevel><creatorcontrib>Ghosh, Partho</creatorcontrib><creatorcontrib>Haque, Md Aynal</creatorcontrib><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Engineering Collection</collection><collection>Engineering Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ghosh, Partho</au><au>Haque, Md Aynal</au><format>book</format><genre>document</genre><ristype>GEN</ristype><atitle>ResDTA: Predicting Drug-Target Binding Affinity Using Residual Skip Connections</atitle><jtitle>arXiv.org</jtitle><date>2023-03-20</date><risdate>2023</risdate><eissn>2331-8422</eissn><abstract>The discovery of novel drug target (DT) interactions is an important step in the drug development process. The majority of computer techniques for predicting DT interactions have focused on binary classification, with the goal of determining whether or not a DT pair interacts. Protein ligand interactions, on the other hand, assume a continuous range of binding strength values, also known as binding affinity, and forecasting this value remains a difficulty. As the amount of affinity data in DT knowledge-bases grows, advanced learning techniques such as deep learning architectures can be used to predict binding affinities. In this paper, we present a deep-learning-based methodology for predicting DT binding affinities using just sequencing information from both targets and drugs. The results show that the proposed deep learning-based model that uses the 1D representations of targets and drugs is an effective approach for drug target binding affinity prediction and it does not require additional chemical domain knowledge to work with. The model in which high-level representations of a drug and a target are constructed via CNNs that uses residual skip connections and also with an additional stream to create a high-level combined representation of the drug-target pair achieved the best Concordance Index (CI) performance in one of the largest benchmark datasets, outperforming the recent state-of-the-art method AttentionDTA and many other machine-learning and deep-learning based baseline methods for DT binding affinity prediction that uses the 1D representations of targets and drugs.</abstract><cop>Ithaca</cop><pub>Cornell University Library, arXiv.org</pub><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | EISSN: 2331-8422 |
ispartof | arXiv.org, 2023-03 |
issn | 2331-8422 |
language | eng |
recordid | cdi_proquest_journals_2789557358 |
source | Free E- Journals |
subjects | Affinity Binding Computer techniques Deep learning Drugs Knowledge bases (artificial intelligence) Machine learning Representations |
title | ResDTA: Predicting Drug-Target Binding Affinity Using Residual Skip Connections |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T13%3A43%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=document&rft.atitle=ResDTA:%20Predicting%20Drug-Target%20Binding%20Affinity%20Using%20Residual%20Skip%20Connections&rft.jtitle=arXiv.org&rft.au=Ghosh,%20Partho&rft.date=2023-03-20&rft.eissn=2331-8422&rft_id=info:doi/&rft_dat=%3Cproquest%3E2789557358%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2789557358&rft_id=info:pmid/&rfr_iscdi=true |